furosemide has been researched along with Critical Illness in 52 studies
Furosemide: A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.
furosemide : A chlorobenzoic acid that is 4-chlorobenzoic acid substituted by a (furan-2-ylmethyl)amino and a sulfamoyl group at position 2 and 5 respectively. It is a diuretic used in the treatment of congestive heart failure.
Critical Illness: A disease or state in which death is possible or imminent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To study whether furosemide infusion in early-onset acute kidney injury (AKI) in critically ill children would be associated with a reduced proportion of patients progressing to the higher stage (Injury or Failure) as compared to placebo." | 9.41 | Trial of Furosemide to Prevent Acute Kidney Injury in Critically Ill Children: A Double-Blind, Randomized, Controlled Trial. ( Abraham, S; Bhowmick, R; Chidambaram, M; Mahadevan, S; Maulik, K; Rameshkumar, R; Sheriff, A; Soundravally, R; Subramani, S, 2021) |
| " 49 adult critically ill patients with hypoalbuminemia and generalized edema who received randomly furosemide and furosemide/albumin complex were enrolled." | 9.34 | Efficacy of furosemide-albumin compared with furosemide in critically ill hypoalbuminemia patients admitted to intensive care unit: a prospective randomized clinical trial. ( Asgharian, P; Hamishehkar, H; Mahmoodpoor, A; Pourakbar, A; Shadvar, K; Shahabi, F; Zahedi, S, 2020) |
| "Furosemide is commonly prescribed in acute kidney injury (AKI)." | 9.24 | The effect of low-dose furosemide in critically ill patients with early acute kidney injury: A pilot randomized blinded controlled trial (the SPARK study). ( Bagshaw, SM; Bellomo, R; Gibney, RTN; Hassan, I; Kruger, P; McAlister, FA, 2017) |
| "To validate the furosemide stress test (FST) for predicting the progression of acute kidney injury (AKI)." | 7.91 | The furosemide stress test for prediction of worsening acute kidney injury in critically ill patients: A multicenter, prospective, observational study. ( Bagshaw, SM; Chawla, LS; Koyner, JL; Liu, KD; McMahon, B; Rewa, OG; Shapiro, J; Smith, O; Trevino, SA; Wald, R; Wang, X, 2019) |
| "To assess safety and effectiveness of a clinical application of a furosemide infusion protocol in edematous critically ill patients." | 7.78 | Clinical outcomes of a furosemide infusion protocol in edematous patients in the intensive care unit. ( Bezdjian, L; Hopkins, RO; Rodriguez, L; Thomsen, G, 2012) |
| "We evaluated the effect of ultrasonically nebulized furosemide (20 mg) on dyspnea uncontrollable by standard therapy in patients with terminal cancer." | 7.72 | Effect of nebulized furosemide in terminally ill cancer patients with dyspnea. ( Aoe, K; Kohara, H; Maeda, T; Saito, R; Shima, Y; Takeyama, H; Uchitomi, Y; Ueoka, H, 2003) |
| "Furosemide was associated with reduced in-hospital mortality [hazard ratio (HR) 0." | 5.56 | Association between furosemide administration and outcomes in critically ill patients with acute kidney injury. ( Hong, GL; Li, MF; Lü, WB; Lu, ZQ; Wu, B; Xu, C; Yao, YM; Ying, JC; Zhao, GJ, 2020) |
| "To study whether furosemide infusion in early-onset acute kidney injury (AKI) in critically ill children would be associated with a reduced proportion of patients progressing to the higher stage (Injury or Failure) as compared to placebo." | 5.41 | Trial of Furosemide to Prevent Acute Kidney Injury in Critically Ill Children: A Double-Blind, Randomized, Controlled Trial. ( Abraham, S; Bhowmick, R; Chidambaram, M; Mahadevan, S; Maulik, K; Rameshkumar, R; Sheriff, A; Soundravally, R; Subramani, S, 2021) |
| "Age, use of furosemide, and septic shock were predictors of AKI in critically ill patients." | 5.38 | Furosemide is associated with acute kidney injury in critically ill patients. ( Almeida, DN; Cruz, CM; Levi, TM; Martins, RT; Rocha, MS; Sanjuan, IT; Santana, NC; Silva, MG, 2012) |
| " 49 adult critically ill patients with hypoalbuminemia and generalized edema who received randomly furosemide and furosemide/albumin complex were enrolled." | 5.34 | Efficacy of furosemide-albumin compared with furosemide in critically ill hypoalbuminemia patients admitted to intensive care unit: a prospective randomized clinical trial. ( Asgharian, P; Hamishehkar, H; Mahmoodpoor, A; Pourakbar, A; Shadvar, K; Shahabi, F; Zahedi, S, 2020) |
| "Furosemide is commonly prescribed in acute kidney injury (AKI)." | 5.24 | The effect of low-dose furosemide in critically ill patients with early acute kidney injury: A pilot randomized blinded controlled trial (the SPARK study). ( Bagshaw, SM; Bellomo, R; Gibney, RTN; Hassan, I; Kruger, P; McAlister, FA, 2017) |
| " While sulfonamide antibiotics are frequently implicated as causative agents for DRESS syndrome, furosemide, a nonantibiotic sulfonamide, has not been routinely reported as the causative agent despite its widespread use." | 4.98 | Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome Secondary to Furosemide: Case Report and Review of Literature. ( Dumic, I; James, J; Nordin, TA; Sammour, YM; Virata, AR, 2018) |
| "Using the Stewart model, increases in SID as an indicator of metabolic alkalosis due to the chloruretic effects of furosemide were observed." | 3.96 | Acid-base effects of continuous infusion furosemide in clinically stable surgical ICU patients: an analysis based on the Stewart model. ( Conn, K; Connor, KA; Haas, CE; Kaufman, DC, 2020) |
| "To validate the furosemide stress test (FST) for predicting the progression of acute kidney injury (AKI)." | 3.91 | The furosemide stress test for prediction of worsening acute kidney injury in critically ill patients: A multicenter, prospective, observational study. ( Bagshaw, SM; Chawla, LS; Koyner, JL; Liu, KD; McMahon, B; Rewa, OG; Shapiro, J; Smith, O; Trevino, SA; Wald, R; Wang, X, 2019) |
| "Prospective cohort observational study of 15 patients with septic AKI undergoing continuous veno-venous hemodiafiltration (CVVHDF) divided according to urine volume (< 500 ml/12 h, Oliguria group, n = 5; > 500 ml/12 h, Diuresis group, n = 10) during continuous infusion of furosemide (120 mg/12 h) at steady-state condition." | 3.88 | Urine volume as a predicting factor for furosemide clearance during continuous infusion in AKI septic shock patients on hemodiafiltration. ( Biancone, L; Carignano, P; Leporati, M; Mariano, F; Stella, M; Vincenti, M, 2018) |
| "To assess safety and effectiveness of a clinical application of a furosemide infusion protocol in edematous critically ill patients." | 3.78 | Clinical outcomes of a furosemide infusion protocol in edematous patients in the intensive care unit. ( Bezdjian, L; Hopkins, RO; Rodriguez, L; Thomsen, G, 2012) |
| "We evaluated the effect of ultrasonically nebulized furosemide (20 mg) on dyspnea uncontrollable by standard therapy in patients with terminal cancer." | 3.72 | Effect of nebulized furosemide in terminally ill cancer patients with dyspnea. ( Aoe, K; Kohara, H; Maeda, T; Saito, R; Shima, Y; Takeyama, H; Uchitomi, Y; Ueoka, H, 2003) |
| "Spironolactone is an aldosterone antagonist that promotes natriuresis and may attenuate such hypernatraemia, but its effect in this setting has not been previously studied." | 2.73 | Pilot randomised double-blind controlled trial of high-dose spironolactone in critically ill patients receiving a frusemide infusion. ( Apte, Y; Bellomo, R; Gillies, M; Goldsmith, D; McGain, F; Warrillow, S, 2008) |
| " Dosing regimens of frusemide, and acetaminophen, and the sizes of ductus arteriosus following treatment, were evaluated." | 1.62 | Intravenous frusemide does not interact pharmacodynamically with acetaminophen in critically ill preterm neonates with patent ductus arteriosus. ( Al Ansari, E; Al Jufairi, M; Al Madhoob, A; Al Marzooq, R; Sridharan, K, 2021) |
| "Furosemide was associated with reduced in-hospital mortality [hazard ratio (HR) 0." | 1.56 | Association between furosemide administration and outcomes in critically ill patients with acute kidney injury. ( Hong, GL; Li, MF; Lü, WB; Lu, ZQ; Wu, B; Xu, C; Yao, YM; Ying, JC; Zhao, GJ, 2020) |
| " Data on demographic, clinical, fluid intake/output, and furosemide and chlorothiazide dosing were collected." | 1.46 | Efficacy of sequential nephron blockade with intravenous chlorothiazide to promote diuresis in cardiac intensive care infants. ( Akcan-Arikan, A; Bronicki, RA; Checchia, PA; Kennedy, C; Moffett, BS; Tsang, R, 2017) |
| "Age, use of furosemide, and septic shock were predictors of AKI in critically ill patients." | 1.38 | Furosemide is associated with acute kidney injury in critically ill patients. ( Almeida, DN; Cruz, CM; Levi, TM; Martins, RT; Rocha, MS; Sanjuan, IT; Santana, NC; Silva, MG, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (5.77) | 18.2507 |
| 2000's | 7 (13.46) | 29.6817 |
| 2010's | 25 (48.08) | 24.3611 |
| 2020's | 17 (32.69) | 2.80 |
| Authors | Studies |
|---|---|
| Khera, D | 1 |
| Paul, B | 1 |
| Goyal, JP | 1 |
| Rameshkumar, R | 2 |
| Fox, HM | 1 |
| DeCleene, JH | 1 |
| Hasson, DC | 1 |
| Zhang, B | 1 |
| Krallman, K | 1 |
| Rose, JE | 1 |
| Kempton, KM | 1 |
| Steele, P | 1 |
| Devarajan, P | 1 |
| Goldstein, SL | 1 |
| Alder, MN | 1 |
| Zhang, K | 1 |
| Zhang, H | 1 |
| Zhao, C | 2 |
| Hu, Z | 1 |
| Shang, J | 1 |
| Chen, Y | 1 |
| Huo, Y | 1 |
| Li, B | 1 |
| Guo, S | 1 |
| Zhao, GJ | 1 |
| Xu, C | 1 |
| Ying, JC | 1 |
| Lü, WB | 1 |
| Hong, GL | 1 |
| Li, MF | 1 |
| Wu, B | 1 |
| Yao, YM | 1 |
| Lu, ZQ | 1 |
| Connor, KA | 1 |
| Conn, K | 1 |
| Kaufman, DC | 1 |
| Haas, CE | 1 |
| Mahmoodpoor, A | 1 |
| Zahedi, S | 1 |
| Pourakbar, A | 1 |
| Hamishehkar, H | 2 |
| Shadvar, K | 1 |
| Asgharian, P | 1 |
| Shahabi, F | 1 |
| Gao, S | 1 |
| Yang, L | 1 |
| Wang, Z | 1 |
| Wernly, B | 1 |
| Heramvand, N | 1 |
| Mirna, M | 1 |
| Kelm, M | 1 |
| Lichtenauer, M | 1 |
| Dudzinski, D | 1 |
| Jung, C | 1 |
| López Pérez, V | 1 |
| Tebar Cuesta, MY | 1 |
| Mesa Ruiz, JL | 1 |
| Arcas Bellas, JJ | 1 |
| Kevorkian, JP | 1 |
| Riveline, JP | 1 |
| Vandiedonck, C | 1 |
| Girard, D | 1 |
| Galland, J | 1 |
| Féron, F | 1 |
| Gautier, JF | 1 |
| Mégarbane, B | 1 |
| Bolgiaghi, L | 1 |
| Umbrello, M | 1 |
| Formenti, P | 1 |
| Coppola, S | 1 |
| Sabbatini, G | 1 |
| Massaro, C | 1 |
| Damiani, M | 1 |
| Chiumello, D | 1 |
| Sridharan, K | 1 |
| Al Madhoob, A | 1 |
| Al Jufairi, M | 1 |
| Al Ansari, E | 1 |
| Al Marzooq, R | 1 |
| Ostermann, M | 2 |
| Lumlertgul, N | 1 |
| Abraham, S | 1 |
| Chidambaram, M | 1 |
| Soundravally, R | 1 |
| Subramani, S | 1 |
| Bhowmick, R | 1 |
| Sheriff, A | 1 |
| Maulik, K | 1 |
| Mahadevan, S | 1 |
| McMahon, BA | 1 |
| Chawla, LS | 2 |
| Lee, SJ | 1 |
| Kim, CW | 1 |
| Lee, MK | 1 |
| Kim, SH | 1 |
| Yong, SJ | 1 |
| Lee, WY | 1 |
| Huang, A | 1 |
| Luethi, N | 1 |
| Mårtensson, J | 1 |
| Bellomo, R | 6 |
| Cioccari, L | 2 |
| Bagshaw, SM | 4 |
| Gibney, RTN | 1 |
| Kruger, P | 1 |
| Hassan, I | 1 |
| McAlister, FA | 2 |
| Shann, F | 1 |
| James, J | 1 |
| Sammour, YM | 1 |
| Virata, AR | 1 |
| Nordin, TA | 1 |
| Dumic, I | 1 |
| Ng, KT | 1 |
| Velayit, A | 1 |
| Khoo, DKY | 1 |
| Mohd Ismail, A | 1 |
| Mansor, M | 1 |
| Jung, YH | 1 |
| Steppan, J | 1 |
| Goeddel, LA | 1 |
| Burns, AR | 1 |
| Ho, KM | 1 |
| Fernandes, FM | 1 |
| Silva, EP | 1 |
| Martins, RR | 1 |
| Oliveira, AG | 1 |
| Oczkowski, SJW | 1 |
| Klotz, L | 1 |
| Mazzetti, I | 2 |
| Alshamsi, F | 1 |
| Chen, ML | 1 |
| Foster, G | 1 |
| Meade, MO | 2 |
| Hamielec, C | 2 |
| Mariano, F | 1 |
| Leporati, M | 1 |
| Carignano, P | 1 |
| Stella, M | 1 |
| Vincenti, M | 1 |
| Biancone, L | 1 |
| Jeon, J | 1 |
| Kim, DH | 1 |
| Baeg, SI | 1 |
| Lee, EJ | 1 |
| Chung, CR | 1 |
| Jeon, K | 1 |
| Lee, JE | 1 |
| Huh, W | 1 |
| Suh, GY | 1 |
| Kim, YG | 1 |
| Kim, DJ | 1 |
| Oh, HY | 1 |
| Jang, HR | 1 |
| Gundogan, K | 1 |
| Akbudak, IH | 1 |
| Bulut, K | 1 |
| Temel, S | 1 |
| Sungur, M | 1 |
| Guven, M | 1 |
| Dave, NJ | 1 |
| Griffith, DP | 1 |
| Ziegler, TR | 1 |
| Schmid, SM | 1 |
| Cianciolo, RE | 1 |
| Drobatz, KJ | 1 |
| Sanchez, M | 1 |
| Price, JM | 1 |
| King, LG | 1 |
| Rewa, OG | 1 |
| Wang, X | 1 |
| Wald, R | 1 |
| Smith, O | 1 |
| Shapiro, J | 1 |
| McMahon, B | 1 |
| Liu, KD | 2 |
| Trevino, SA | 1 |
| Koyner, JL | 1 |
| Oczkowski, SJ | 1 |
| Moffett, BS | 1 |
| Tsang, R | 1 |
| Kennedy, C | 1 |
| Bronicki, RA | 1 |
| Akcan-Arikan, A | 1 |
| Checchia, PA | 1 |
| Slater, MB | 1 |
| Gruneir, A | 1 |
| Rochon, PA | 1 |
| Howard, AW | 1 |
| Koren, G | 1 |
| Parshuram, CS | 1 |
| Michaud, CJ | 1 |
| Mintus, KC | 1 |
| Apte, Y | 1 |
| Warrillow, S | 1 |
| Goldsmith, D | 1 |
| Gillies, M | 1 |
| McGain, F | 1 |
| Gibney, RT | 1 |
| Grams, ME | 1 |
| Estrella, MM | 1 |
| Coresh, J | 1 |
| Brower, RG | 1 |
| Levi, TM | 1 |
| Rocha, MS | 1 |
| Almeida, DN | 1 |
| Martins, RT | 1 |
| Silva, MG | 1 |
| Santana, NC | 1 |
| Sanjuan, IT | 1 |
| Cruz, CM | 1 |
| Runge Sørensen, C | 1 |
| Madsen, JK | 1 |
| Schmidt, F | 1 |
| Sloth, E | 1 |
| Thomsen, G | 1 |
| Bezdjian, L | 1 |
| Rodriguez, L | 1 |
| Hopkins, RO | 1 |
| Kohara, H | 1 |
| Ueoka, H | 1 |
| Aoe, K | 1 |
| Maeda, T | 1 |
| Takeyama, H | 1 |
| Saito, R | 1 |
| Shima, Y | 1 |
| Uchitomi, Y | 1 |
| Jain, M | 1 |
| Canham, M | 1 |
| Upadhyay, D | 1 |
| Corbridge, T | 1 |
| Graham, CA | 1 |
| Delaney, A | 1 |
| Haase, M | 1 |
| Ghali, WA | 1 |
| Alvarez, G | 1 |
| Sharpe, MD | 1 |
| Martin, CM | 1 |
| Yetman, AT | 1 |
| Singh, NC | 1 |
| Parbtani, A | 1 |
| Loft, JA | 1 |
| Linley, MA | 1 |
| Johnson, CC | 1 |
| Morgan, D | 1 |
| Luciani, GB | 1 |
| Nichani, S | 1 |
| Chang, AC | 1 |
| Wells, WJ | 1 |
| Newth, CJ | 1 |
| Starnes, VA | 1 |
| Klinge, J | 1 |
| McLintic, AJ | 1 |
| Metcalfe, MJ | 1 |
| Ingram, KS | 1 |
| Dougall, JR | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase II Randomized Blinded Controlled Trial of the Effect of furoSemide in Critically Ill Patients With eARly Acute Kidney Injury (The SPARK Study)[NCT00978354] | Phase 2/Phase 3 | 72 participants (Actual) | Interventional | 2009-09-30 | Terminated (stopped due to Feasibility of target enrollment within the context of available funding resources.) | ||
| Observational Study to Evaluate the Effects on the Qt Interval of COVID-19 Coronavirus Infection in Critically Ill Patients[NCT04422535] | 80 participants (Anticipated) | Observational | 2020-05-29 | Recruiting | |||
| A Single-centre, Randomized, Double-blinded, Placebo-controlled Pilot Study to Determine the Feasibility of a Full-scale Clinical Trial to Compare the Effect of Furosemide With or Without 25% Albumin in the Diuresis of Edema in Volume-overloaded ICU Patie[NCT02055872] | Phase 3 | 46 participants (Actual) | Interventional | 2014-09-30 | Completed | ||
| Predicting Acute Kidney Injury in Infants Exposed to Nephrotoxic Drugs: A Big Data Approach to Predict NEOnatal Acute Kidney Injury in Newborns expoSed to nephroTOxic Drugs. (NeoAKI STOP)[NCT05851222] | 4,200 participants (Anticipated) | Observational | 2023-08-01 | Not yet recruiting | |||
| "Early and Late Timing Indication for Starting Renal Replacement Therapy in Acute Renal Failure After Cardiac Surgery: a Prospective, Controlled, Interventional, Single-center Trial"[NCT01961999] | 1,800 participants (Actual) | Interventional | 2011-07-31 | Completed | |||
| Phase III Study of Furosemide Continuous Infusion Versus Ethacrynic Acid Continuous Infusion in Children Undergoing Cardiac Surgery: Randomized Double Blind Controlled Clinical Trial[NCT01628731] | Phase 3 | 74 participants (Actual) | Interventional | 2012-10-31 | Completed | ||
| Agreement Test of Intravascular Volume Assessment Between Inferior Vena Cava (IVC) Diameter and Vascular Pedicle Width (VPW)[NCT03535038] | 35 participants (Actual) | Interventional | 2018-05-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 reviews available for furosemide and Critical Illness
| Article | Year |
|---|---|
The furosemide stress test: current use and future potential.
Topics: Acute Kidney Injury; Critical Illness; Diuretics; Electrolytes; Exercise Test; Furosemide; Humans; R | 2021 |
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome Secondary to Furosemide: Case Report and Review of Literature.
Topics: Biopsy, Needle; Combined Modality Therapy; Critical Care; Critical Illness; Diuretics; Drug Hypersen | 2018 |
Continuous Infusion versus Intermittent Bolus Injection of Furosemide in Critically Ill Patients: A Systematic Review and Meta-analysis.
Topics: Critical Illness; Diuretics; Furosemide; Global Health; Humans; Infusions, Intravenous; Survival Rat | 2018 |
Pharmacological therapy of acute cardiogenic pulmonary oedema in the emergency department.
Topics: Acute Disease; Analgesics, Opioid; Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Cri | 2004 |
Loop diuretics in the management of acute renal failure: a systematic review and meta-analysis.
Topics: Acid-Base Equilibrium; Acute Kidney Injury; Creatinine; Critical Illness; Data Interpretation, Stati | 2007 |
13 trials available for furosemide and Critical Illness
| Article | Year |
|---|---|
Trial of Furosemide to Prevent Acute Kidney Injury in Critically Ill Children: A Double-Blind, Randomized, Controlled Trial: Correspondence.
Topics: Acute Kidney Injury; Child; Critical Illness; Diuretics; Double-Blind Method; Furosemide; Humans | 2022 |
Trial of Furosemide to Prevent Acute Kidney Injury in Critically Ill Children: A Double-Blind, Randomized, Controlled Trial: Author's Reply.
Topics: Acute Kidney Injury; Child; Critical Illness; Diuretics; Double-Blind Method; Furosemide; Humans | 2022 |
The furosemide stress test predicts the timing of continuous renal replacement therapy initiation in critically ill patients with acute kidney injury: a double-blind prospective intervention cohort study.
Topics: Acute Kidney Injury; Cohort Studies; Continuous Renal Replacement Therapy; Critical Illness; Exercis | 2023 |
Efficacy of furosemide-albumin compared with furosemide in critically ill hypoalbuminemia patients admitted to intensive care unit: a prospective randomized clinical trial.
Topics: Aged; Aged, 80 and over; Critical Illness; Diuretics; Edema; Female; Furosemide; Humans; Hypoalbumin | 2020 |
Trial of Furosemide to Prevent Acute Kidney Injury in Critically Ill Children: A Double-Blind, Randomized, Controlled Trial.
Topics: Acute Kidney Injury; Child; Child, Preschool; Critical Illness; Double-Blind Method; Furosemide; Hum | 2021 |
The effect of low-dose furosemide in critically ill patients with early acute kidney injury: A pilot randomized blinded controlled trial (the SPARK study).
Topics: Acute Disease; Acute Kidney Injury; Aged; Critical Illness; Diuretics; Double-Blind Method; Female; | 2017 |
Furosemide and Albumin for Diuresis of Edema (FADE): A parallel-group, blinded, pilot randomized controlled trial.
Topics: Adult; Aged; Albumins; Critical Illness; Diuresis; Diuretics; Female; Fluid Therapy; Furosemide; Hum | 2018 |
Furosemide and albumin for diuresis of edema (FADE): a study protocol for a randomized controlled trial.
Topics: Albumins; Critical Illness; Diuresis; Diuretics; Edema; Furosemide; Oxygen; Pilot Projects; Plasma S | 2014 |
Pilot randomised double-blind controlled trial of high-dose spironolactone in critically ill patients receiving a frusemide infusion.
Topics: Aged; Critical Care; Critical Illness; Diuretics; Double-Blind Method; Female; Furosemide; Humans; H | 2008 |
The SPARK Study: a phase II randomized blinded controlled trial of the effect of furosemide in critically ill patients with early acute kidney injury.
Topics: Acute Disease; Adult; Alberta; Biomarkers; Critical Illness; Disease Progression; Diuretics; Female; | 2010 |
The SPARK Study: a phase II randomized blinded controlled trial of the effect of furosemide in critically ill patients with early acute kidney injury.
Topics: Acute Disease; Adult; Alberta; Biomarkers; Critical Illness; Disease Progression; Diuretics; Female; | 2010 |
The SPARK Study: a phase II randomized blinded controlled trial of the effect of furosemide in critically ill patients with early acute kidney injury.
Topics: Acute Disease; Adult; Alberta; Biomarkers; Critical Illness; Disease Progression; Diuretics; Female; | 2010 |
The SPARK Study: a phase II randomized blinded controlled trial of the effect of furosemide in critically ill patients with early acute kidney injury.
Topics: Acute Disease; Adult; Alberta; Biomarkers; Critical Illness; Disease Progression; Diuretics; Female; | 2010 |
The SPARK Study: a phase II randomized blinded controlled trial of the effect of furosemide in critically ill patients with early acute kidney injury.
Topics: Acute Disease; Adult; Alberta; Biomarkers; Critical Illness; Disease Progression; Diuretics; Female; | 2010 |
The SPARK Study: a phase II randomized blinded controlled trial of the effect of furosemide in critically ill patients with early acute kidney injury.
Topics: Acute Disease; Adult; Alberta; Biomarkers; Critical Illness; Disease Progression; Diuretics; Female; | 2010 |
The SPARK Study: a phase II randomized blinded controlled trial of the effect of furosemide in critically ill patients with early acute kidney injury.
Topics: Acute Disease; Adult; Alberta; Biomarkers; Critical Illness; Disease Progression; Diuretics; Female; | 2010 |
The SPARK Study: a phase II randomized blinded controlled trial of the effect of furosemide in critically ill patients with early acute kidney injury.
Topics: Acute Disease; Adult; Alberta; Biomarkers; Critical Illness; Disease Progression; Diuretics; Female; | 2010 |
The SPARK Study: a phase II randomized blinded controlled trial of the effect of furosemide in critically ill patients with early acute kidney injury.
Topics: Acute Disease; Adult; Alberta; Biomarkers; Critical Illness; Disease Progression; Diuretics; Female; | 2010 |
Frusemide administration in critically ill patients by continuous compared to bolus therapy.
Topics: Aged; Critical Illness; Diuretics; Dose-Response Relationship, Drug; Female; Furosemide; Humans; Inf | 2007 |
Acute hemodynamic and neurohoromonal effects of furosemide in critically ill pediatrics patients.
Topics: Adolescent; Age Factors; Analysis of Variance; Child; Child, Preschool; Critical Illness; Diuresis; | 1996 |
Continuous versus intermittent furosemide infusion in critically ill infants after open heart operations.
Topics: Cardiac Output, Low; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Critical Illness; Diuretic | 1997 |
34 other studies available for furosemide and Critical Illness
| Article | Year |
|---|---|
Relationship Between Mean Arterial Pressure and Furosemide Stress Test Success Rates: A Retrospective Cohort Study.
Topics: Adult; Arterial Pressure; Cohort Studies; Critical Illness; Exercise Test; Furosemide; Humans; Retro | 2023 |
Acute kidney injury biomarker olfactomedin 4 predicts furosemide responsiveness.
Topics: Acute Kidney Injury; Biomarkers; Child; Critical Illness; Furosemide; Humans | 2023 |
Association between furosemide administration and outcomes in critically ill patients with acute kidney injury.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Critical Illness; Diuretics; Female; Furosemide; Human | 2020 |
Acid-base effects of continuous infusion furosemide in clinically stable surgical ICU patients: an analysis based on the Stewart model.
Topics: Acid-Base Equilibrium; Aged; Aged, 80 and over; Alkalosis; Critical Care; Critical Illness; Diuretic | 2020 |
Do critically ill patients with AKI benefit from furosemide? Further real-word evidence from a large multi-center database.
Topics: Acute Kidney Injury; Critical Illness; Data Management; Diuretics; Furosemide; Humans | 2020 |
Testing House of God's Law VII: Was the Fat Man Right?
Topics: Adult; Critical Care; Critical Illness; Databases, Factual; Diuretics; Drug Dosage Calculations; Fem | 2020 |
Management of hypertensive crisis with clevidipine in the perioperative setting of a critically ill patient, non-responder to high doses of nitroglycerin, labelatol, urapidil, doxazosin and furosemide.
Topics: Critical Illness; Doxazosin; Furosemide; Humans; Nitroglycerin; Piperazines; Pyridines | 2021 |
Early short-course corticosteroids and furosemide combination to treat non-critically ill COVID-19 patients: An observational cohort study.
Topics: Adrenal Cortex Hormones; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Cohort Studies; Comorbid | 2021 |
The furosemide stress test, electrolyte response and Renal Index in critically ill patients.
Topics: Acute Kidney Injury; Critical Illness; Diuretics; Electrolytes; Exercise Test; Furosemide; Humans; I | 2021 |
Intravenous frusemide does not interact pharmacodynamically with acetaminophen in critically ill preterm neonates with patent ductus arteriosus.
Topics: Acetaminophen; Administration, Intravenous; Critical Illness; Ductus Arteriosus, Patent; Female; Fur | 2021 |
Predicting AKI: do we have the necessary tools?
Topics: Acute Kidney Injury; Critical Illness; Electrolytes; Exercise Test; Furosemide; Humans | 2021 |
Effect of high-dose furosemide on the prognosis of critically ill patients.
Topics: Adult; Critical Illness; Diuretics; Dose-Response Relationship, Drug; Female; Furosemide; Humans; Ma | 2017 |
Pharmacodynamics of intravenous frusemide bolus in critically ill patients.
Topics: Aged; Cohort Studies; Critical Illness; Dose-Response Relationship, Drug; Electrolytes; Female; Furo | 2017 |
Pharmacodynamics of intravenous frusemide bolus in critically ill patients.
Topics: Critical Illness; Furosemide; Humans; Infusions, Intravenous; Injections, Intravenous | 2017 |
Pharmacodynamics of intravenous frusemide bolus in critically ill patients.
Topics: Critical Illness; Furosemide; Humans; Infusions, Intravenous; Injections, Intravenous | 2017 |
Continuous Versus Bolus Furosemide in the Critically Ill: More Questions than Answers.
Topics: Critical Illness; Diuretics; Furosemide; Humans; Infusions, Intravenous; Injections, Intravenous | 2018 |
Urinary potassium excretion and its association with acute kidney injury in the intensive care unit.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Aged, 80 and over; Area Under Curve; Biomarkers; Chlor | 2018 |
QTc interval prolongation in critically ill patients: Prevalence, risk factors and associated medications.
Topics: Adult; Aged; Amiodarone; Clopidogrel; Critical Illness; Cross-Sectional Studies; Electrocardiography | 2018 |
Urine volume as a predicting factor for furosemide clearance during continuous infusion in AKI septic shock patients on hemodiafiltration.
Topics: Acute Kidney Injury; Adult; Aged; Critical Illness; Diuresis; Diuretics; Female; Furosemide; Hemodia | 2018 |
Association between diuretics and successful discontinuation of continuous renal replacement therapy in critically ill patients with acute kidney injury.
Topics: Acute Kidney Injury; Aged; Cohort Studies; Critical Illness; Diuretics; Female; Furosemide; Humans; | 2018 |
Thiamin Status in Adults Receiving Chronic Diuretic Therapy Prior to Admission to a Medical Intensive Care Unit: A Pilot Study.
Topics: Adult; Aged; Case-Control Studies; Critical Illness; Diuretics; Female; Furosemide; Hospitalization; | 2019 |
Postmortem evaluation of renal tubular vacuolization in critically ill dogs.
Topics: Acute Kidney Injury; Animals; Autopsy; Creatinine; Critical Care; Critical Illness; Diuretics; Dog D | 2019 |
The furosemide stress test for prediction of worsening acute kidney injury in critically ill patients: A multicenter, prospective, observational study.
Topics: Acute Kidney Injury; Aged; Area Under Curve; Critical Illness; Disease Progression; Female; Furosemi | 2019 |
Efficacy of sequential nephron blockade with intravenous chlorothiazide to promote diuresis in cardiac intensive care infants.
Topics: Chlorothiazide; Critical Care; Critical Illness; Diuresis; Diuretics; Dose-Response Relationship, Dr | 2017 |
Identifying High-Risk Medications Associated with Acute Kidney Injury in Critically Ill Patients: A Pharmacoepidemiologic Evaluation.
Topics: Acute Kidney Injury; Adolescent; Case-Control Studies; Child; Child, Preschool; Critical Illness; Dr | 2017 |
Intravenous Chlorothiazide Versus Enteral Metolazone to Augment Loop Diuretic Therapy in the Intensive Care Unit.
Topics: Administration, Intravenous; Administration, Oral; Adult; Chlorothiazide; Critical Illness; Diuresis | 2017 |
Fluid balance, diuretic use, and mortality in acute kidney injury.
Topics: Acute Kidney Injury; Acute Lung Injury; Critical Illness; Diuretics; Female; Fluid Therapy; Furosemi | 2011 |
Furosemide is associated with acute kidney injury in critically ill patients.
Topics: Acute Kidney Injury; Aged; Critical Illness; Diuretics; Female; Furosemide; Humans; Intensive Care U | 2012 |
[No evidence for renal protective effect of loop diuretics for patients having oliguria].
Topics: Acute Kidney Injury; Critical Illness; Diuresis; Evidence-Based Medicine; Fluid Therapy; Furosemide; | 2012 |
Clinical outcomes of a furosemide infusion protocol in edematous patients in the intensive care unit.
Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; Critical Care; Critical Illness; Diuretics; Dose-Res | 2012 |
Effect of nebulized furosemide in terminally ill cancer patients with dyspnea.
Topics: Chloride Channels; Critical Illness; Dyspnea; Furosemide; Humans; Nebulizers and Vaporizers; Neoplas | 2003 |
Variability in interventions with pulmonary artery catheter data.
Topics: Attitude of Health Personnel; Cardiotonic Agents; Catheterization, Swan-Ganz; Critical Care; Critica | 2003 |
Intermittent administration of furosemide or continuous infusion in critically ill infants and children: does it make a difference?
Topics: Acute Kidney Injury; Child; Critical Illness; Furosemide; Humans; Infant; Infusions, Intravenous; In | 2001 |
Acute mitral regurgitation: physiological and pharmacological considerations in the management of a critically ill patient.
Topics: Acute Disease; Combined Modality Therapy; Critical Illness; Dopamine; Female; Furosemide; Humans; In | 1992 |